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Abstract
Introduction: In areas of pulmonary embolism (PE), the enhancement of pulmonary veins on computed 
tomography pulmonary angiography (CTPA) should be decreased due to reduced arterial perfusion. 
The purpose of this study was to investigate the accuracy of contrast density measurements (differences) in all 
pulmonary veins and the left atrium for the prediction of PE.
Material and methods: Seventy-five patients with PE and 22 patients without PE on CTPA were included. 
Four readers measured the enhancement of the blood in the pulmonary vein immediately before the entrance to 
the left atrium, right after the aperture, in the center of the left atrium, in the pulmonary trunk and in the aorta. 
Enhancement of the pulmonary veins with and without upstream PE, and ROC curves with HU thresholds for 
optimal sensitivity and specificity for PE were calculated. 
Results: More PEs were found in the right and lower lobes. PE-affected lobes demonstrated 13.8 ± 45 HU 
less enhancement in the pulmonary vein, compared to a paired non-affected pulmonary vein of the same pa-
tient (P < 0.0001). On average, non-affected pulmonary veins demonstrated no difference in enhancement 
compared to each other: 0.2 ± 21 HU. The optimal cutoff level in the ROC curve analysis for PE affection 
proved to be decreasing enhancement in the pulmonary vein of more than 10 HU compared to the atrium. 
Conclusion: Decreasing enhancement in the pulmonary vein of more than 10 HU compared to the atrium 
could provide additional information and confidence in the diagnosis of PE. 
Key words: pulmonary embolism detection, CT-pulmonary angiography, enhancement and 
perfusion of pulmonary veins
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Introduction
Pulmonary embolism (PE) is a common disease 
with a potentially poor patient outcome. A thrombus 
occluding the pulmonary artery causes obstruction of 
lung circulation and can result in cardiogenic shock and 
death. Often, PE is not clinically recognized because the 
symptoms can be very unspecific and therefore can have 
low diagnostic value [1, 2]. Symptoms by themselves do 
not make it possible to exclude PE or to confirm it [1, 2]. 
To decide on diagnostic steps and additional therapy, 
risk stratification is crucial [1]. Established clinical 
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scores, such as the Wells score [3, 4] or the Geneva 
score [5, 6], classify patients into low-, intermediate- 
and high-risk categories. These scores include patients’ 
risk factors for PE, symptoms and clinical signs [3–6].
Correct and immediate diagnosis, as well as man-
agement and initiation of treatment, is important for 
patient outcomes [7].
In intermediate- and high-risk patients, multidetec-
tor row computed tomography pulmonary angiography 
(CTPA) is the procedure of choice and has become 
the gold standard when PE is suspected [2, 8–11]. The 
overriding characteristics of PE in CTPA are an occlusive 
or non-occlusive filling defect inside a pulmonary artery 
[12, 13]. When the vessel is fully occluded, it can appear 
expanded, and the thrombus can form an acute angle 
with the artery wall [12–14]. A partial filling defect, in 
which the thrombus is surrounded by a contrasting 
agent, is called a “polo mint sign”, occurring on images 
perpendicular to the long axis of the vessel [12]. On 
longitudinal images of the vessels, it is called the “railway 
track sign” [12].
Secondary findings in CTPA, such as an enlarged 
diameter of the pulmonary artery (“Pallas Sign”), at-
electasis, pulmonary infarction (“Hamptons hump”), 
pleural effusion and oligemia (“Westmark sign”) can 
provide additional proof of PE in cases of uncertainty, 
but they are unspecific [13, 15–17]. Furthermore, the 
signs of pulmonary hypertension and cardiac congestion 
— such as right ventricular dilation, horizontalization 
or deviation of the interventricular septum and con-
trast reflux into liver veins — can facilitate detecting 
or confirming the PE diagnosis. The PE sensitivity of 
these right ventricular congestion signs was reported 
as being as high as 78% [2]. Filling defects in pulmonary 
veins adjacent to PE was recently described by Souza 
et al [18]. This “Pulmonary Vein Sign” was defined as 
presence of homogeneous filling defect in a pulmonary 
vein in the last 2 cm from the left atrium. This visual sign 
only reached a PE sensitivity of 36% by radiologists. 
The purpose of this study was to investigate the 
accuracy of contrast density measurements (differenc-
es) in all pulmonary veins and the left atrium for the 
prediction of pulmonary embolism since the contrast in 
pulmonary veins should be decreased due to reduced 
arterial perfusion in areas of PE.
Material and methods
IRB approval was waived due to the retrospective 
nature of the study with irreversible anonymization.
Inclusion/exclusion of patients
Our Radiology Information System (Centricity RIS-i 6, 
General Electric Company, GE Healthcare, Chicago, 
IL, USA) was searched for the diagnosis of PE. Over 
a time period of 2 years (2016 and 2017), 82 consecutive 
patients with pulmonary embolisms were submitted to 
CTPA at our institution. Two senior radiologists with 10 
and 12 years of experience in chest imaging reviewed 
the images for diagnosis confirmation and mapping of 
the PE (see ground truth below). In 3 patients, the di-
agnosis of PE could not be verified on CTPA, and these 
patients were excluded (low contrast or beam harden-
ing artifacts). Of the remaining 79 patients, 4 had to be 
excluded due to lobectomy or severe motion artifacts. 
Twenty-three patients demonstrated embolisms in the 
drainage locations of all four pulmonary veins and were 
used for PE distribution and arterial enhancement sta-
tistics, but were excluded from the work-up of different 
enhancement in the pulmonary veins (Fig. 1). Twenty-two 
age- and sex-matched patients with normal CTPA exams 
and without PE findings were added as a control group. 
CT imaging
CT images were acquired by two CT scanners 
(both by Siemens Healthcare, Erlangen, Germany): 
a SOMATOM Definition Flash (128 × 0.6 mm, pitch 0.6, 
slice thickness 1 mm) and a SOMATOM Definition Edge 
(128 × 0.6 mm, pitch 0.6, slice thickness 1 mm). A CT 
tube voltage of 100 kVp and a reference CT current 
time product of 100 mA were used. Standard contrast 
medium with 300 mg/mL iodine concentration was 
used at a flow rate of 4 mL/s (Xenetix 300; Guerbet, 
Aulnay-sous-Bois, France). A region of interest (ROI) 
was placed in the pulmonary trunk. Image acquisition 
started 4 seconds after the threshold of 100 Hounsfield 
units (HU) was reached in the ROI. Iterative recon-
Figure 1. PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) with the inclusion of 82 patients 
and exclusion of 7 and 23 patients
82 patients with PE identified 
in RIS (Radiology Information 
System)
75 PE (distribution analyzed)
52 PE (venous density analyzed)




due to PE in
all lobes
4 patients excluded 
due to lobectomy
3 PE not confirmed
by expert lobectomy
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struction (SAFIRE, level 3) was performed using kernels 
I26f and I70f.
Ground truth
In the remaining 75 cases, the mapping of the PE 
was reported in consensus by two senior radiologists 
with 10 and 12 years of experience in chest imaging. 
The PEs were classified as follows: central (involving the 
right or left main pulmonary artery), lobar, segmental 
or subsegmental PEs in the upper or lower lobe on the 
right or left side. Every embolus was counted separately 
and was noted with the most proximal affection of the 
pulmonary artery. Since the middle lobe and the lingula 
drain into the upper pulmonary veins, they counted 
as the upper lobes. In case of an additional lingular or 
middle lobe vein (normal variants), the mean densities 
of the upper lobe vein and the additional vein were 
calculated. Any aforementioned location of PE counted 
as a positive lobar result. 
CT image analysis
The readouts were generated using a Picture 
Archiving and Communication System (PACS Philips, 
Amsterdam, Netherlands and Sectra, Linköping, 
Sweden). Group 1 consisted of two readers with 10 
and 3 years of chest imaging experience, and group 2 
consisted of two radiologists with 8 and 1 year(s) of 
chest imaging experience; both groups measured the 
4 pulmonary veins in 97 cases (388 ROIs). The readers 
from group 1 placed the ROI (region of interest) into 
the vein immediately before the entrance into the left 
atrium, and the readers in group 2 set the ROI in the 
atrium, as close as possible to the venous aperture 
(Fig. 2). In addition, the readers also measured the 
density of the blood in the center of the left atrium, 
in the pulmonary trunk and in the middle of the aortic 
arc. After 4 weeks, the two groups remeasured the 
4 pulmonary veins in half of the cases (n = 50) for 
intra-reader variability.
Statistics
Any form of embolism, even an isolated subseg-
mental PE, counted as affected pulmonary vein with an 
upstream PE. The mean enhancement of the pulmonary 
veins with and without upstream PE was calculated and 
compared to each other using Wilcoxon’s unpaired rank 
sum test. In addition, the paired enhancement of the 
1 to 3 normal veins and the 1 to 3 embolism-affected 
veins per patient were analyzed using Wilcoxon’s 
paired rank sum test. Additionally, the average density 
difference of the veins within the same patient and the 
difference in the density to the atrium were calculated 
and analyzed by Wilcoxon’s test. The results of both 
readers in the groups counted separately for the reader 
correlation, and the mean of their results was used for 
Wilcoxon’s test. For the determination of the best cutoff 
level for (1) enhancement differences between atrium 
and pulmonary veins and (2) enhancement differences 
of the veins (normal vs. upstream embolism) receiver 
operator characteristic curves (ROC) were generated 
to find the area under the curve (AUC) and the optimal 
sensitivity and specificity (confidence interval included). 
Figure 2. Density measurement in: A — the right inferior pulmonary vein; and B — the left inferior pulmonary vein. The readers 
in group 1 placed the ROI (region of interest, red circle) in the vein immediately before the entrance into the left atrium, and the 
readers in group 2 set the ROI in the atrium, as close as possible to the venous aperture (yellow circle) 
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Intra- and inter-reader correlations were determined 
with Pearson’s correlation coefficient.
All tests of significance were two-tailed, and 
a P-value of < 0.05 was considered to indicate statistical 
significance. Calculations were performed with Med-
Calc® software, version 16.4.3 (MedCalc Software, 
Ostend, Belgium).
Results
Seventy-five patients with pulmonary embolism 
(male:female = 40:37, mean age = 61.6 ± 16.2 years 
old) and 22 normal control patients (m:f = 11:11, mean 
age 60.2 ± 16.2 years old) were included. The emboli 
were classified as follows: 24 central, 43 lobar, 53 seg-
mental and 47 subsegmental (Table 1). More PEs were 
found in the right and lower lobes, and more isolated 
subsegmental PEs were found on the left side (Table 1). 
In 21, 22, 9 and 23 patients one, two, three or four 
lobes, respectively, were affected by PEs. 
Group 1: on average, the pulmonary vein of 
a PE-affected lobe was 13.8 ± 45 HU less enhanced than 
a paired non-affected pulmonary vein of the same 
patient (P < 0.0001, Fig. 3). Group 2: these paired 
measurements did not demonstrate significant differ-
ences (mean difference = 7.8 ± 48 HU, P = 0.336). 
In group 1, the mean and median enhancement 
differences from an affected vein to the atrium (HUat-
rium-HUpv) were 5.1 ± 3.8 and 8.5 (CI: –4.2 to 
15.0), respectively; meanwhile the mean and median 
enhancement differences from an unaffected vein to the 
atrium (HUatrium-HUpv) were –3.1 ± 2.1 HU and –2 
HU (CI: –7.9 to 1.0), respectively. These enhancement 
differences were significant (affected vs. unaffected: 
P = 0.0052). 
The optimal cutoff level in the ROC analysis for 
PE affection proved to be decreasing enhancement in 
the pulmonary vein of more than 10 HU, compared 
to the atrium (Fig. 4). The AUC for this ROC curve 
was 0.57 (CI: 0.51 to 0.63) with sensitivity of 47.8% 
(37.3–58.5%) and specificity of 74.7% (67.4–81.1%). 
Group 2, who measured in the left atrium closest to 
the venous aperture did not score significantly different 
enhancements between veins with or without upstream 
PEs (P = 0.31). Figure 5 demonstrates the venous en-
hancement differences (HUatrium-HUpv) depending 
on the number of embolism-affected lobes with the 
largest distinction found between patients without PE 
and with one PE. A specific ROC curve analysis (Fig. 6) 
of these patient selections found an AUC of 0.785 
(CI: 0.70 to 0.86) with the best sensitivity of 85.7% 
(63.6–96.8%) and specificity of 63.5% (53.1–73.1%) 
using the criterion of > 3 HU (difference in HU be-
tween atrium and pulmonary vein). Again, no significant 
differences were found for group 2.
Generally, the blood density in the pulmonary trunk 
(PT) was higher than that in the left atrium (LA), and it 
was higher in the LA than in the aorta in both groups 
(Table 2). In patients with pulmonary embolisms, the 
Table 1. Distribution of pulmonary emboli (total emboli load)
PE   R L R+L
Central*   14 10 24
lobar ul 11 7  
  ll 14 11  
  ul+ll 25 18 43
Segmental ul 11 8  
  ll 17 17  
  ul+ll 28 25 53
Subsegmental ul 4 8  
  ll 14 21  
  ul+ll 18 29 47
total ul       73
total ll       94
total ul+ll 85 82  
Number of patients
1 lobe PE (1 drainage vein) 21
2 lobes PE (2 drainage veins) 22  
3 lobe PE (3 drainage veins) 9  
4 lobes PE (all drainage veins) 23
*pulmonary trunk or main pulmonary artery
UL: upper lobe; LL lower lobe; R: right; L: left; PE: pulmonary embolism
Figure 3. A 57-year-old male patient with a segmental pulmo-
nary embolism in the anterior-lateral artery of the left lower 
lobe (orange arrow). The left pulmonary vein of the lower 
lobe demonstrated less enhancement than the right side
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density along this track was at each point higher than 
in the patients without embolisms (P = 0.046 for all 3 
measurements in the PT, LA and aorta in both groups 
combined).
There was no significant difference in the mean 
absolute pulmonary vein density (non-paired), wheth-
er in cases with or without pulmonary embolisms 
(P > 0.1742). The means and medians of the pulmonary 
vein density in groups 1 and 2 for the different embolism 
categories are indicated in Table 3. 
Both the inter- and intra-reader correlations were 
very high: the intra-reader correlations of the 4 readers 
were ≥ 0.93 (CI: 0.91 to 0.95). The inter-reader cor-
relations in the groups and between the groups were 
≥ 0.92 (CI: 0.91 to 0.94), although the ROIs were set 
slightly differently.
Discussion
In this study, we found that the veins in the drainage 
area of the PEs had, on average, 14 HU less enhance-
ment than the veins of unclogged areas (P < 0.0001). 
For practical reasons, we also provided results for the 
measurement differences between the atrium and pul-
monary veins (when comparing veins, one never knows 
whether the vein compared is free of embolisms). An 
attenuation difference of +10 HU indicates PE when 
applying this technique, with the strength clearly lying 
in the 75% specificity. Especially difficult to find are sol-
itary PEs for radiologists, and for these embolisms, the 
accuracy increased to a sensitivity of 86% (threshold: 
HUatrium-HUpv > 3 HU). Our results indicate up to 
50% higher sensitivities than the “Pulmonary Vein Sign”. 
There could be different reasons for that: First, Souza 
et al. [18] set the ROI into the left atrium to trigger the 
CT exam, in our study the pulmonary trunk was used 
as trigger reference leading to an earlier CT phase. 
Figure 6. Patients with PE affecting only one lobe: ROC curve 
analysis of enhancement differences between the left atrium 
and pulmonary vein (HUatrium-HUpv). Best sensitivity and 
specificity of 85.7% and 63.5%, respectively, were found for 
a threshold of a > 3 HU difference
Figure 4. A 63-year-old male patient suffering from lobar and 
segmental pulmonary embolisms in the right lower lobe (red 
arrows). The right lower pulmonary vein demonstrated less 
enhancement than the normal left lower pulmonary vein and 
the atrium. Note the regular enhancement/perfusion of the 






























Figure 5. Box-and-whisker plot of the enhancement differen-
ce from an affected vein to the left atrium (HUatrium-HUpv) 
in patients without PE and patients with 1 to 4 affected lobes
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Second, we measured HU differences between veins 
and atrium and computed the best cut-off levels for 
PE, while Souza et al. used a visual sign with probably 
rather large enhancement differences that could have 
led to a shift from sensitivity toward specificity. 
As mentioned in the introduction, CTPA is the 
method of choice when detecting PE. It has very high 
sensitivity (90%) and specificity (94%) [14, 19–23]. In 
CTPA, PE is diagnosed by detecting a partial or fully 
occluded artery. Generally, the vessel density before 
(pulmonary trunk) and after the PE (left atrium) was 
higher, compared to the non-embolic cases. Pulmonary 
embolisms increase the pulmonary arterial resistance 
and pressure and can lead to a certain delay in cir-
culation, which in turn can lead to accumulation of 
contrast media in the heart/lung. Therefore, one could 
expect high pulmonary vessel density in patients with 
PE. However, the clogged lobes are prone to lesser 
perfusion with less intravascular contrast media, which 
might be why the absolute vein density did not differ 
between any of the clogged and non-clogged lobes. The 
difference could only be found by comparing the veins 
in the same patient. In cases in which all four lobs are 
affected, there should be no HU difference. However, 
in these patients the diagnosis of PE requires no further 
sign for confidence boosting since all of the lobes are 
affected, and PE can usually be found easily.
More isolated subsegmental PEs were found on the 
left side (Table 1), likely because, on the right side, the 
subsegments were already occupied by larger segmen-
tal or lobar Pes. 
Group 2 demonstrated a larger SD of the focal 
density measurement in the region of interest (ROI), 
indicating that the ROI was set larger due to larger 
space within the atrium (compared to the measurement 
within the veins for group 1); therefore, there was more 
noise and a larger SD.
Secondary findings can help in evaluation, especially 
in cases of uncertainty, and they have been described 
as predictors of severity and outcome [24]. However, 
there is disagreement in the literature in regard to their 
value in detecting PE, as well as predicting severity and 
outcome. They can distract from and interfere with the 
diagnosis of PE, thus presenting a potential pitfall [24]. 
Engelke et al. described sporadic secondary findings in 
cases of PE diagnosis that did not contribute to its de-
tection [24]. They found PE burden to have the highest 
value for detection. However, they excluded pleural 
effusion from their study, which is more closely asso-
ciated with PE. Similarly, contrast density differences 
between the pulmonary veins could be used to detect 
PE, especially, when there is doubt.
Other parameters can be utilized for the predic-
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was described as a predictor of severity by Ghaye 
et al. [25] and Araoz et al. [26], yet it cannot predict 
clinical outcomes. Another predictor of severity but 
not outcome is right ventricular failure [26]. Previous 
studies have found cardiac parameters to be superi-
or in predicting the patient’s clinical outcomes [26]. 
According to Bilj et al., the best predictor of clinical 
illness-specific outcomes is the right to left ventricular 
ratio [27]; nevertheless, the sample size in this study 
was very small. The vein enhancement measurements 
applied in this study could also be used in the future to 
help predict severity and outcome. 
There are some limitations in our study: no clas-
sifications according to PE severity, secondary cardio-
pulmonary diseases or patient outcome were made. 
Anatomical anomalies of pulmonary vessels, such as 
the normal variants of pulmonary veins (e.g., additional 
veins), bronchopulmonary sequester, lung transplan-
tation, dystelectasis, and structural lung disease, for 
example fibrosis, COPD or tissue scars, could perhaps 
account for the reduction in contrast density and are 
potential reasons for wrong density values. These pit-
falls can be easily detected with CT and must be con-
sidered when interpreting contrast density reductions 
in pulmonary veins.
Additionally, CT-tube voltage plays a role in the 
absorption fraction and the density measurements of 
contrast media and must be kept constant. For example, 
low-dose CTPA for pregnant women can detect differ-
ent venous enhancement due to lower CT-tube voltage 
and different blood volumes [28–34]. Enhancement of 
the pulmonary veins is highly dependent on the delay 
phase of the scan; therefore, the mean density did not 
prove to be useful, but the differences in enhancement 
within the same patent kept this variable out of the 
equation. All of these factors must be considered before 
utilizing this technique since they can distort density 
values and affect measurements.
In conclusion, decreasing enhancement in the pul-
monary vein can provide additional information and 
confidence in the diagnosis of PE. 
It is important to measure the blood density within 
the pulmonary veins right before the aperture and not 
after the aperture into the left atrium; and subtract it 
from the blood density in the center of the left atrium. 
An attenuation difference of >10 HU indicates PE when 
applying this technique, with the strength clearly lying 
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